Erratum: Fragile sites are preferential targets for integrations of MLV vectors in gene therapy (Gene Therapy (2006) vol. 13 (1057-1059) 10.1038/

A. C. Bester, M. Schwartz, M. Schmidt, A. Garrigue, S. Hacein-Bey-Abina, M. Cavazzana-Calvo, N. Ben-Porat, C. Von Kalle, A. Fischer, B. Kerem

Research output: Contribution to journalComment/debate

Original languageAmerican English
Pages (from-to)282
Number of pages1
JournalGene Therapy
Issue number3
StatePublished - Feb 2007

Cite this